TAK
$18.48
Revenue | $1213211.32Mn |
Net Profits | $105509.96Mn |
Net Profit Margins | 8.7% |
Takeda Pharmaceutical Company Limited’s revenue jumped 6.04% since last year same period to $1213211.32Mn in the Q4 2025. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated 9.02% jump in its revenue since last 3-months.
Takeda Pharmaceutical Company Limited’s net profit jumped 343.52% since last year same period to $105509.96Mn in the Q4 2025. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated 994% jump in its net profits since last 3-months.
Takeda Pharmaceutical Company Limited’s net profit margin jumped 318.27% since last year same period to 8.7% in the Q4 2025. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated 920.01% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.15 |
EPS Estimate Current Year | 0.15 |
Takeda Pharmaceutical Company Limited’s earning per share (EPS) estimates for the current quarter stand at 0.15 - a -24.73% fall from last quarter’s estimates.
Takeda Pharmaceutical Company Limited’s earning per share (EPS) estimates for the current year stand at 0.15.
Earning Per Share (EPS) | 0.21 |
Takeda Pharmaceutical Company Limited’s earning per share (EPS) jumped 339.12% since last year same period to 0.21 in the Q4 2025. This indicates that the Takeda Pharmaceutical Company Limited has generated 339.12% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-07-30 | 0.2 | 151 | 75174.18% |
2025-06-25 | -0.17 | -0.23 | -37.11% |
2025-10-30 | 0.15 | -0.03 | -116.75% |